Andrea K Miyahira1, Jelani C Zarif2,3, Catherine C Coombs4, Robert R Flavell5,6, Joshua W Russo7, Samir Zaidi8, Di Zhao9, Shuang G Zhao10, Kenneth J Pienta11, Howard R Soule1. 1. Department of Science, Prostate Cancer Foundation, Santa Monica, California, USA. 2. Department of Oncology, Johns Hopkins University School of Medicine and The Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, USA. 3. Bloomberg Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. 4. Division of Hematology, Department of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA. 5. Department of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, California, USA. 6. Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, California, USA. 7. Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA. 8. Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York, USA. 9. Department of Experimental Radiation Oncology, MD Anderson Cancer Center, Houston, Texas, USA. 10. Department of Human Oncology, Carbone Cancer Center, University of Wisconsin, Madison, Wisconsin, USA. 11. The James Buchanan Brady Urological Institute, The Johns Hopkins School of Medicine, Baltimore, Maryland, USA.
Abstract
INTRODUCTION: The 2021 Coffey-Holden Prostate Cancer Academy (CHPCA) Meeting, "Prostate Cancer Research in the 21st Century," was held virtually, from June 24-25, 2021. METHODS: The CHPCA Meeting is organized by the Prostate Cancer Foundation as a unique discussion-oriented meeting focusing on critical topics in prostate cancer research envisioned to bridge the next major advances in prostate cancer biology and treatment. The 2021 CHPCA Meeting was virtually attended by 89 investigators and included 31 talks over nine sessions. RESULTS: Major topic areas discussed at the meeting included: cancer genomics and sequencing, functional genomic approaches to studying mediators of plasticity, emerging signaling pathways in metastatic castration resistant prostate cancer, Wnt signaling biology and the challenges of targeted therapy, clonal hematopoiesis, neuroendocrine cell plasticity and antitumor immunity, cancer immunotherapy and its synergizers, and imaging the tumor microenvironment and metabolism. DISCUSSION: This meeting report summarizes the research presented at the 2021 CHPCA Meeting. We hope that publication of this knowledge will accelerate new understandings and the development of new biomarkers and treatments for prostate cancer.
INTRODUCTION: The 2021 Coffey-Holden Prostate Cancer Academy (CHPCA) Meeting, "Prostate Cancer Research in the 21st Century," was held virtually, from June 24-25, 2021. METHODS: The CHPCA Meeting is organized by the Prostate Cancer Foundation as a unique discussion-oriented meeting focusing on critical topics in prostate cancer research envisioned to bridge the next major advances in prostate cancer biology and treatment. The 2021 CHPCA Meeting was virtually attended by 89 investigators and included 31 talks over nine sessions. RESULTS: Major topic areas discussed at the meeting included: cancer genomics and sequencing, functional genomic approaches to studying mediators of plasticity, emerging signaling pathways in metastatic castration resistant prostate cancer, Wnt signaling biology and the challenges of targeted therapy, clonal hematopoiesis, neuroendocrine cell plasticity and antitumor immunity, cancer immunotherapy and its synergizers, and imaging the tumor microenvironment and metabolism. DISCUSSION: This meeting report summarizes the research presented at the 2021 CHPCA Meeting. We hope that publication of this knowledge will accelerate new understandings and the development of new biomarkers and treatments for prostate cancer.
Authors: Kristin L Granlund; Sui-Seng Tee; Hebert A Vargas; Serge K Lyashchenko; Ed Reznik; Samson Fine; Vincent Laudone; James A Eastham; Karim A Touijer; Victor E Reuter; Mithat Gonen; Ramon E Sosa; Duane Nicholson; YanWei W Guo; Albert P Chen; James Tropp; Fraser Robb; Hedvig Hricak; Kayvan R Keshari Journal: Cell Metab Date: 2019-09-26 Impact factor: 27.287
Authors: Min Zou; Roxanne Toivanen; Antonina Mitrofanova; Nicolas Floch; Sheida Hayati; Yanping Sun; Clémentine Le Magnen; Daniel Chester; Elahe A Mostaghel; Andrea Califano; Mark A Rubin; Michael M Shen; Cory Abate-Shen Journal: Cancer Discov Date: 2017-04-14 Impact factor: 39.397
Authors: Andrea K Miyahira; Sameek Roychowdhury; Sangeeta Goswami; Joseph E Ippolito; Saul J Priceman; Colin C Pritchard; Karen S Sfanos; Sumit K Subudhi; Jonathan W Simons; Kenneth J Pienta; Howard R Soule Journal: Prostate Date: 2016-09-28 Impact factor: 4.104
Authors: Jun Li; Mercedes A Duran; Eileen E Parkes; Benjamin Izar; Ninjit Dhanota; Walid K Chatila; Sarah E Bettigole; John Kwon; Roshan K Sriram; Matthew P Humphries; Manuel Salto-Tellez; Jacqueline A James; Matthew G Hanna; Johannes C Melms; Sreeram Vallabhaneni; Kevin Litchfield; Ieva Usaite; Dhruva Biswas; Rohan Bareja; Hao Wei Li; Maria Laura Martin; Princesca Dorsaint; Julie-Ann Cavallo; Peng Li; Chantal Pauli; Lee Gottesdiener; Benjamin J DiPardo; Travis J Hollmann; Taha Merghoub; Hannah Y Wen; Jorge S Reis-Filho; Nadeem Riaz; Shin-San Michael Su; Anusha Kalbasi; Neil Vasan; Simon N Powell; Jedd D Wolchok; Olivier Elemento; Charles Swanton; Alexander N Shoushtari; Samuel F Bakhoum Journal: Cancer Discov Date: 2020-12-28 Impact factor: 39.397
Authors: Laura Crowley; Francesco Cambuli; Luis Aparicio; Maho Shibata; Brian D Robinson; Shouhong Xuan; Weiping Li; Hanina Hibshoosh; Massimo Loda; Raul Rabadan; Michael M Shen Journal: Elife Date: 2020-09-11 Impact factor: 8.140
Authors: Maha Hussain; Joaquin Mateo; Karim Fizazi; Fred Saad; Neal Shore; Shahneen Sandhu; Kim N Chi; Oliver Sartor; Neeraj Agarwal; David Olmos; Antoine Thiery-Vuillemin; Przemyslaw Twardowski; Guilhem Roubaud; Mustafa Özgüroğlu; Jinyu Kang; Joseph Burgents; Christopher Gresty; Claire Corcoran; Carrie A Adelman; Johann de Bono Journal: N Engl J Med Date: 2020-09-20 Impact factor: 91.245
Authors: Dae-Hwan Kim; Duanchen Sun; William K Storck; Katherine Welker Leng; Chelsea Jenkins; Daniel J Coleman; David Sampson; Xiangnan Guan; Anbarasu Kumaraswamy; Eva S Rodansky; Joshua A Urrutia; Jacob A Schwartzman; Chao Zhang; Himisha Beltran; Mark P Labrecque; Colm Morrissey; Jared M Lucas; Ilsa M Coleman; Peter S Nelson; Eva Corey; Samuel K Handelman; Jonathan Z Sexton; Rahul Aggarwal; Wassim Abida; Felix Y Feng; Eric J Small; Daniel E Spratt; Armand Bankhead; Arvind Rao; Emily M Gesner; Sarah Attwell; Sanjay Lakhotia; Eric Campeau; Joel A Yates; Zheng Xia; Joshi J Alumkal Journal: Clin Cancer Res Date: 2021-06-18 Impact factor: 12.531